Pay in 4 interest-free payments of $36.25 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
486427-17-2
plays a key role in tumor cell proliferation and tumor vascularization
Harmine was dosed orally to obese db/db mice at 30 mg/kg
InChiKey: VLARLSIGSPVYHX-UHFFFAOYSA-N
GGTI-298 TFA - CAS# 1217457-86-7 60002 486427-17-2GGTI 298 TFA, CAS No. 1217457 86 7, is a potent geranylgeranyltransferase I (GGTase I) inhibitor with potential antitumor actrivity. GGTI 298 disrupts MAP kinase activation and G(1) S transition in Ki Ras overexpressing transformed adrenocortical cells. GGTI 298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin dependent kinase inhibitors. A potential mechanism for GGTI 298 antitumor activity. GGTI 298 arrests human tumor
US$ 500.00
US$ 15.00
US$ 14.95
US$ 13.95
US$ 14.99